disease and is approached commonly by both open surgery and laparoscopy or another minimally invasive approach. Outcomes after adrenalectomy have been examined by surgeon specialty, 6 operative approach, 7, 8 and presence of malignancy, 7 with readmission rates between 1.5% and 11.3% reported, 6,7 , 9 but specific risk factors for readmission after adrenalectomy have not been reported previously.
Given the increasing frequency of adrenalectomy, identifying risk factors for readmission in these specific patients may help to guide preoperative planning and postoperative care. Because adrenalectomy is not a common procedure, the American College of Surgeons' National Surgical Quality Improvement Program Database (ACS-NSQIP) allows for examination of a comprehensive, large, national cohort to overcome the limitations associated with single-center studies. Our goal was to use ACS-NSQIP to identify risk factors for readmission after adrenalectomy during the preoperative, postoperative, and intraoperative phases of care, as well as to examine risk of readmission, morbidity, and mortality based on operative approach and type of adrenal disease for which adrenalectomy was performed.
Methods

Patient identification, classification, and collection
All cases with adrenalectomy as the primary procedure were identified in the ACS-NSQIP database from years 2011-2015. Current procedural terminology (CPT) codes were used to identify these cases and included 60540 (adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar, or dorsal), 60545 (... with excision of adjacent retroperitoneal tumor), and 60650 (laparoscopy, surgical, with adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal). Patients were excluded if 30-day readmission status was unknown. All variables included in the ACS-NSQIP database and common over all 5 years were examined. Variables with high rates of null values were excluded.
Variables were categorized based on when the variable would be known definitively to a clinician caring for a patient. Preoperative variables included age, sex, race, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, known comorbidities, and adrenal disease diagnosis. Known comorbidities included diabetes, smoking status, chronic obstructive pulmonary disease, dyspnea, ventilator dependence, ascites, congestive heart failure, hypertension on medication, preoperative acute kidney injury, dialysis use, disseminated cancer, steroid use, > 10% weight loss within 6 months of operation, and bleeding disorders. Adrenal disease was identified using the ICD-9 or ICD-10 associated with each of the cases which were categorized by authors A.C.B, G.L, J.R.H., and R.J.W. into the most appropriate category. A substantial portion of patients (29%) had an ICD-9 or ICD-10 recorded in the NSQIP database that was unspecified adrenal disease or a disease that did not fit a commonly accepted indication for adrenalectomy (eg, gastroparesis) and were thus categorized as unspecified/unknown. Although some diagnoses are only confirmed postoperatively, we included the diagnosis as one of the preoperative variables. Operative variables included admission status, operative approach, elective compared with nonelective surgery, operative time, total work relative value units (RVUs), and wound classification. Elective surgery is defined by NSQIP as the patient coming from home. Operative time, total work RVUs, blood transfusions, and additional procedures were used as surrogates for operative complexity.
Postoperative variables included hospital duration of stay, discharge destination, return to operating room, blood transfusion, wound complications, systemic infectious complications, and other systemic complications. Wound complications consisted of superficial surgical site infections (SSI), deep SSI, organ/space SSI, and wound disruptions. Systemic infectious complications included pneumonia, urinary tract infection, sepsis, and septic shock. Other systemic complications were defined as cardiopulmonary complications, including unplanned intubation, ventilatory support > 48 hours, cardiac arrest, and myocardial infarction; progressive renal insufficiency or acute renal failure; venous thrombotic event, including pulmonary embolus or deep venous thrombosis; and cerebrovascular accidents.
Statistical analysis
Statistical analysis was performed using SPSS Statistics (IBM, Armonk, NY). Continuous variables were represented as the mean ± standard deviation (SD), and categorical variables as the median and interquartile range (IQR). Unpaired Student's t test and Pearson's correlation were used to examine continuous variables. The Mann-Whitney test, Spearman correlations, and Kruskal-Wallis test were used to examine categorical variables. Multivariate logis- tic regression was used to generate odds ratios and identify confounders and was run separately for preoperative, intraoperative, and postoperative variables. Variables with P values ≤ 0.2 on univariate analysis were included in multivariate analysis. Significance was defined as a P value < 0.05.
Results
Over this period, 659, 243, and 3,387 patients were identified with CPT codes 60540, 60545, and 60650, respectively. Readmission status was unknown for 68 patients, and these were excluded from further analysis. There was a trend toward an increase in the annual number of patients who underwent adrenalectomy as a primary procedure reported in the database from 2011 to 2015 ( Fig 1 ) ; however, the number of cases per institution decreased. The median time from operation to discharge was 2 days (IQR 1-4). There were 216 (5.1%) patients readmitted within 30 days of adrenalectomy, which occurred at a median of 14 (IQR 7-21) days after discharge.
Preoperative variables associated with readmission
On univariate analysis, ASA classification, diabetes, dialysis, disseminated cancer, bleeding disorders, primary adrenal malignancy, and injury/hemorrhage were all associated with increased rates of readmission ( Table 1 ) . Although a diagnosis of adrenal injury or hemorrhage was rare, occurring in only 0.1% of patients, this diagnosis was associated with a readmission rate of 40%, which was the greatest rate for any of the variables. Patients with adrenal injury or hemorrhage were more likely to undergo nonelective operations compared with all patients undergoing adrenalectomy (80% vs 7.2%, P < 0.001). Additionally, these patients were more likely to have open procedures (60% vs 21%, P = 0.032) and had greater rates of blood transfusion (80% vs 7.2%, P < .001). All cases of adrenal injury or hemorrhage ( n = 5) were coded with adrenalectomy as the primary procedure and, in addition, the ICD-9 codes 868.04, 86 8.01, 56 8.81, 459, and 998.12. Three cases had additional procedures performed. Adrenalectomy for a benign neoplasm was the only variable associated with a decreased risk of readmission.
Intraoperative variables associated with readmission
A number of intraoperative variables were analyzed for association with readmission rates ( Table 2 ) . A laparoscopic approach was used in 79% of patients, and the risk of readmission was less compared with that of patients who underwent open adrenalectomy (4.3 vs. 8.0%, P < .001). Patients who required readmission had a greater mean operative time compared with patients not readmitted (171 ± 94 minutes vs 150 ± 81 minutes, P < .001). Interestingly, wound classification was not associated with readmission rates; however, 98.7% of cases were clean or clean/contaminated. Total work RVUs were used as an indication for the complexity of the operation and were associated with an increased rate of readmission ( P < .001). Additional procedures were performed in 736 (17.4%) patients and were associated with higher rates of readmission ( P < .001). The most common procedures included cholecystectomy (92, 12.5%), lysis of adhesions (80, 10.8%), liver biopsy or resection (54, 7.3%), hernia repair (36, 4.9%), and partial or complete nephrectomy (32, 4.3%).
An elective indication for adrenalectomy was associated with a decrease in readmission ( P < .001); 6.9% of procedures were nonelective, and 0.3% were unknown. Nonelective cases occurred in patients with adrenal diseases as follows: primary malignancy ( n = 30), nonadrenal primary malignancy (17) , benign neoplasm (122), Cushing's disease/syndrome (13), pheochromocytoma (5), carcinoid (unknown whether a primary carcinoid of the adrenal or a metastasis) (1), hyperaldosteronism (7), gluco-or mineralocorticoid deficiency (2), adrenal injury or hemorrhage (4), and unknown/unspecified (105).
Postoperative variables associated with readmission
All postoperative complications except for wound dehiscence were associated with a higher rate of 30-day readmission on univariate analysis ( Table 3 ) . Infectious complications were the most common variable associated with readmissions. Longer durations of stay were associated with higher readmission rates ( P < .001). Discharge destination was associated with readmission, with a higher readmission rate for patients who were discharged to a skilled nursing facility and a lower readmission rate for those discharged home ( P < .001). Seventeen (0.4%) deaths occurred, and 4 within the population of 216 patients (1.9%) were readmitted ( P = .001).
Association of type of adrenal disease with outcome
Patients undergoing adrenalectomy with primary adrenal malignancy as the primary diagnosis had a readmission rate of 8.2%, which was statistically different from that of all patients undergoing adrenalectomy ( Table 4 ) . Patients with any malignancy were more likely to have an ASA classification ≥3 preoperatively (76% vs 67.9%, P < .001) and higher rates of disseminated cancer (44.6% vs 1.9%, P < .001) than patients overall. Compared with all patients undergoing adrenalectomy, patients undergoing adrenalectomy for malignancy were more likely to undergo open adrenalectomy (44.2% vs 21.0%, P < .001) and had longer mean operative times (181 ± 98 minutes vs 151 ± 82 minutes, P < .001). Postoperatively, wound complications (4.0% vs 1.9%, P < .001) and blood transfusions (18.5% vs 7.2%, P < .001) were more common in patients with malignancy.
Patients with Cushing's disease/syndrome as the primary diagnosis had a greater ASA classification ( ≥3) preoperatively (88.8% vs 67.9%, P = .011). Operative time was greater in Cushing's disease/syndrome, and these patients were more likely to have undergone laparoscopic surgery ( Table 4 ). The readmission rate (5.6% vs. 5.1%, P = .808) in Cushing's disease/syndrome was similar to that of all patients undergoing adrenalectomy; however, the mortality rate (2.1% vs 0.4%, P < .001) was increased. Additionally, other adrenal diseases were associated with specific postoperative morbidities. Those with pheochromocytomas had higher rates of systemic infections (9.6% vs 3.2%, P = .007) and renal insufficiency or failure (3.8% vs 0.6%, P = .004), with a trend toward higher rates of mor- 
Discussion
Readmission rates for surgical patients have become an important quality metric and also affect incentive payments through the Hospital Readmission and Reduction Program (HRRP). 10, 11 The 30-day hospital readmission rate for general surgical procedures is approximately 11% to 15%, and the rates for readmission have been decreasing over the past decade. 2,4 , 10 The focus on hospital readmission has been driven by a desire to decrease the costs of health care. 11, 12 Although decreasing readmissions through improved discharge planning appears to improve patient satisfaction, the effect on decreasing costs is less clear. 13 In fact, readmission rates after surgery may often relate to complex social issues or medical conditions that may not be related to the index reason for hospital admission. 12, 14 Nevertheless, the current retrospective analysis was undertaken to identify specific variables associated with readmission after adrenalectomy with the intent of identifying potential means to decrease readmission rates for patients undergoing adrenal surgery. Many of the variables identified in the current study that were associated with increased readmission were patient variables that were not likely to be altered by the surgical treatment. Focusing on those parameters that might be altered by preoperative preparation, patient selection, operative approach, or post-operative care may decrease readmissions after adrenalectomy.
Previous studies examining adrenalectomy have reported a substantial variation in overall readmission rates between 2% and 10%. 6,7 , 9 These reports are consistent with the current study with an overall readmission rate of 5.1%. Studies attempting to define risk factors for readmission have focused on a comparison of open adrenalectomy with laparoscopic or other minimally invasive ap-proaches. Although open adrenalectomy has been associated with a greater duration of stay, most studies have failed to identify a significant difference in readmission rates for open compared with minimally invasive adrenalectomy. 7,8 , 15 In the current study, we identified an increase in readmission rate for open adrenalectomy, which remained statistically significant and clinically important on multivariate analysis. A previous study reported a trend for increased readmission for open adrenalectomy compared with a minimally invasive approach, and the failure to identify a difference may have been due to the smaller number of patients in the previous report. 15 Intraoperative adverse events have been reported to increase the risk of readmission in patients undergoing abdominal operations. 16 Avoidance of intraoperative complications may account for the reported association between decreased complications and lower rates of readmission after adrenalectomy for high-volume surgeons. 9, 17 In contrast, studies of emergent general surgical procedures failed to identify a difference in readmission rates between low-volume and high-volume surgeons, even when considering complex operations. 18 Because operative experience in adrenalectomy is known to play an important role in operative time and blood loss, 19 our finding that increased readmission rates were associated with longer operative times and increased transfusion requirements could be partially related to low-volume surgeons, in addition to other patient-related factors. The decrease in number of adrenalectomies performed per institution may be a worrisome trend that could increase readmission rates.
Systemic infections and SSIs were the most important factors influencing readmission. Infectious complications have previously been reported as one of the most important causes of readmission on the general surgery service. 3,4 , 14,20 The current study is one of the few studies to report the incidence of infections after adrenalectomy, and these data may increase our ability to prevent infectious complications. We identified an increase in readmission rates for all complications related to SSI. Recent guidelines have been revised for the prevention of SSI, and recommendations for clean and clean/contaminated cases applied to adrenalectomy are likely to result in decreased SSI rates and decreased readmissions. 21 Previous studies reported that antimicrobial prophylaxis had no effect on SSI rates in clean category, minimally invasive adrenalectomy. 22 Additionally, certain patient-related variables, such as obesity, older age, and diabetes, influence postoperative infectious complications after adrenalectomy. 17,23 , 24 Although these patient-related variables may not be altered by surgical care, their presence may in some cases influence patient selection and/or preoperative preparation.
As reported previously, adrenalectomy for malignant tumors was associated with a higher rate of postoperative complications, including deep vein thrombosis and potential pulmonary embolism, 25 which may be prevented by following appropriate guidelines for venous thromboembolism prophylaxis. In the current study, venous thrombotic events were nearly 12 times more likely in the patients readmitted and could potentially be avoided. Despite this, adrenalectomy for metastatic disease appeared to have acceptable rates of readmission and mortality. Additionally, the largest number of readmissions occurred in patients with a benign neoplasm, because it was the most common adrenal disease even though overall rate of readmission was low (4.2%). This observation emphasizes the multifactorial nature of readmissions and the importance of identifying different types of risk factors that occur during all phases of care.
Specific details regarding the clinical scenarios and operative procedures are not tracked in NSQIP. This limited our ability to assess all specific details of each case that may have influenced readmission. Specifically, we were not able to assess if blood was transfused during a procedure or postoperatively, why a case was nonelective, and what exact scenarios led to adrenalectomy with uncommon indications, such as carcinoid and adrenal injury or hemorrhage.
In conclusion, unplanned readmission after adrenalectomy is related to specific comorbidities, operative parameters, and postoperative complications. Additionally, the adrenal disease for which adrenalectomy is performed correlated with different risks of readmission, and the types of postoperative complications varied with adrenal pathology. The data suggest readmissions after adrenalectomy may be decreased by developing clinical guidelines for VTE prophylaxis and SSI prevention specific for adrenalectomy, expanding use of the laparoscopic approach, and identifying patients with nonmodifiable risk factors for readmission. Identifying patients with a high risk of readmission may allow allocation of resources to decrease both readmissions and health care costs. 
Dr Tina Yen (Milwaukee, WI): Thank you, Dr Beck. That was very nicely presented. You had a wonderful study using the NSQIP database to examine risk factors for 30-day readmission after adrenalectomy. You report a 5.1% 30-day readmission rate and 0.4% death rate. As you summarized, multiple preoperative, intraoperative, and postoperative risk factors tare predictive of readmission, all factors that clinically make intuitive sense.
Based on this, you conclude that the recognition of these factors may assist with preop preparation and improved discharge planning to decrease readmission rates.
I have three questions, which you sort of addressed. The first, I
have not yet personally examined the NSQIP database. Does NSQIP provide information for reasons on return to operating room, readmission, and death? My understanding is that NSQIP defines whether a return to the operating room or readmission was planned or unplanned and related or not related to the primary operation. However, if you had reasons for the reoperation and readmission, if that information was provided, this information would be valuable to include and would further strengthen your conclusions and recommendations.
Secondly, although the rates of wound complication and systemic infectious complications overall were very low at 2% to 3%, as you show, patients with either complication had a 6-fold increased odds of readmission. So what are the current guidelines for antimicrobial prophylaxis for adrenalectomy, both open and laparoscopic, and beyond the general standard recommendations to prevent infections including preoperative, perioperative blood glucose control, Foley removal, etc., how can wound and other infectious complications be better addressed specifically in this population? For example, why do the patients with pheochromocytoma have such a high 9% rate of systemic infection?
Thirdly, VTE events occurred again, very rarely overall, but those who had a VTE event had 11-fold increased odds of being readmitted. Was the reason for readmission related to this VTE in most, if not all, cases? Again, as you sort of allude to in your conclusions, per current oncology society guidelines such as ASCO, should we prophylax all of these patients with malignancy who are undergoing adrenalectomy?
Thank you for a nicely presented paper. Dr Anna C. Beck: Thank you, Dr Yen, for taking the time to review our paper and provide that feedback.
To address your first question, NSQIP does provide the reason for return to operating room and for readmission; however, it's not the most granular data that's available. It's provided by ICD-9 codes with a lot of unspecific codes, so we chose not to include that because we didn't think it would add useful data because that's how nongranular the data was that was available.
To address your second question regarding the infectious complications and the current guidelines, currently, for adrenalectomies, it follows the guidelines based on, like you said, the general laparoscopic or open abdominal surgery guidelines in terms of using perioperative antibiotics for clean or clean contaminated cases, but not continue antibiotics, only using Foley catheters in selective patients, recommending Hibiclens showers. I guess there aren't more specific guidelines at this time specifically for adrenalectomies. However, we propose that perhaps a shorter follow-up might help catch wound infections early, if an incision is slightly red, being able to open up earlier on rather than waiting for it to become an abscess or more purulent.
In terms of the VTE prophylaxis, I agree. I think any adrenal malignancy, when they undergo surgery, it certainly is a large surgery and I think qualifies for the recommended guidelines where patients should be prophylaxed for about 4 weeks after surgery. I think that would be recommended.
Dr Michael Brunt (St. Louis, MO): Congratulations on a nice study and I think important analysis.
The first question is, those patients with adrenal injury or hemorrhage, that's a pretty unusual indication for adrenalectomy. So I was wondering if you have any more information about that. Most cases of adrenal hemorrhage usually are managed conservatively initially and may ultimately down the road at some point, if they don't completely resolve, require surgery, but not usually acutely. That's one question.
The second also relates a little bit to what Dr. Yen was getting at, and that is in the septic and infectious complications, in my experience for laparoscopic adrenalectomy, at least, are distinctly uncommon or should be very uncommon.
I wonder if what you're seeing, this is not something related to antibiotics but it's to another event that happened such as a bowel injury that occurred from access or particularly with left adrenalectomy, and I think this is an underappreciated problem with injury to pancreas, that results in pancreatitis, fluid collection, infected, etc. Do you have any information about that from your population?
Finally, have you thought about looking at your own institutional experience with adrenalectomy to maybe get a little more granular with some of the causes for readmissions? Dr Anna C. Beck: In terms of the adrenal injury and hemorrhage, again, we were also surprised that there were those patients within the database. However, there were only 5 patients out of the 4,0 0 0 or so patients that were included. With such a low rate, we believe that adrenalectomy was likely performed for adrenal injury or hemorrhage, as they were coded since it was such a low percentage of patients. But the way we obtained those data was from a CPT code or ICD-9 or -10 code that follows what the procedure was. And so we can't, unfortunately, learn more about those patients specifically.
In terms of the infectious complications, there may have been additional issues that contributed to infection, I agree. Again, there's only specific complications that are listed in the NSQIP database, and so that was something when we looked at reasons for readmission, it also included a lot of complications that aren't reported specifically as a complication in the NSQIP database, which makes it a little bit hard to look at.
Dr. Yen , I forgot to answer your question about the pheochromocytomas and their higher rates of readmission. In that group, the 9% that had systemic infections, the vast majority of them were due to pneumonia. Perhaps there is something else going on. Perhaps they remained intubated more commonly after surgery, something we proposed, and that might increase their rate for infection. Again, using this database, we can't answer that question. But perhaps doing a review of our own institution, we'll be able to answer that question.
Dr Don Fry (Chicago, IL): I enjoyed this presentation. You're going to find that studying readmissions is a slippery slope, and you're going to have lots of issues that are going to come up. For example, I'm assuming that the NSQIP database has exclusions to what are counted as readmissions or not. So I'm assuming that this is not all-cause readmissions but only those that have been specified by NSQIP.
The NSQIP definitions of readmissions are at great variance with what Medicare considers a readmission, and that's going to be a problem going forward because Medicare is going to disallow a lot of those readmissions under the advanced payment program that's presently being employed.
So I'm asking whether these are all-cause readmissions or not. I didn't see any information about nonmedical causes of readmission. And there's been a lot of discussion about nonmedical variables-patients living a long way from the indexed medical center where they had their operation. Patients that reside in poorer ZIP codes have higher readmission rates than patients that live in wealthy ZIP codes, interestingly, and there are nonmedical issues that influence patients being readmitted.
I'm curious whether you've looked at nonmedical variables that might be influencing which patients are readmitted and which ones are not.
Dr Anna C. Beck: Thank you for that the observation. This does include all-cause readmissions from the NSQIP database. In terms of a nonmedical reason for readmissions, unfortunately, that's not a variable that we can access through the NSQIP database, which, again, is frustrating. Yes, certainly, something that if we did look at our own institution, perhaps we would be able to answer. Iowa specifically does have a lot of rural areas, and the majority of our patients who are coming to us travel 4 or 5 hours just to come to their appointments. It might be a good opportunity to look at that.
Dr Christopher Mchenry (Cleveland, OH): Congratulations on a great presentation. I just have a very short question for you.
When looking at the preoperative variables, Dr. Brunt commented on one, the adrenal hemorrhage and injury. The other two that I thought were odd were emergency adrenalectomy and then also adrenalectomy where the primary diagnosis was carcinoid tumor. Those seem odd to me, because I don't know what would be an emergency adrenalectomy. And personally, in my own experience, I have not done an adrenalectomy for carcinoid tumors. I wonder if you might comment on those two things.
Dr Anna C. Beck: Thank you for the question. The rate of emergency adrenalectomies was 7.2%. There were only 5 patients with adrenal injury or hemorrhage, so only a very small number of patients. We were also surprised to see these patients. We debated including them or not because we do think it is a slightly different population, but we think that it was important to look at those cases even though they were quite rare compared to the rest of the population.
In terms of the carcinoid, yes, we also thought that was interesting. Unfortunately, we weren't given any more information about what type of disease the patient has, whether it was metastatic carcinoid, which we proposed may be the reason for adrenalectomy. I know I didn't present it here, but as that population, they had a significantly higher rate of DVTs and PEs compared to the overall population. So if those are being performed, we thought it was an interesting group to at least discuss.
Dr R. Matthew Walsh (Cleveland, OH): In addition to a strategy of seeing patients earlier, there could be a strategy of identifying a group that you could identify before they left the hospital and potentially scan them if they have a deep-site infection since you have all the fixed costs of running a CT scanner already as an inpatient. Can you identify that group that you may identify something before they leave the hospital? Dr Anna C. Beck: I think so. We're able to look at the timing of complications. No, we didn't report it here. It did vary. Some complications occurred after they were discharged, but some of these complications were occurring before discharge. I think there certainly is the opportunity then to look at those patients. I guess if you recognize these patients by the preoperative and intraoperative variables that it might also clue you into a patient that's at risk.
